PA
Perceptive Advisors Portfolio holdings
AUM
$5.46B
1-Year Est. Return
264.28%
This Fund
S&P 500
1 Year Est. Return
+264.28%
AUM
$5.46B
AUM Growth
+$2B
(+58%)
Holding
131
Top Buys
| 1 | +$80.3M | |
| 2 | +$65.6M | |
| 3 | +$61.6M | |
| 4 |
Exact Sciences
EXAS
|
+$59M |
| 5 |
Dyne Therapeutics
DYN
|
+$55.6M |
Top Sells
| 1 | +$127M | |
| 2 | +$101M | |
| 3 | +$80M | |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$55.9M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$53.9M |
Sector Composition
| 1 | Healthcare | 99.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Praxis Precision Medicines
PRAX
$9.05B
| $588M | 10.78% |
1,995,986
+431,432
|
|
||
2
Celcuity
CELC
$5.19B
| $315M | 5.77% |
3,160,200
+203,881
|
|
||
3
Rhythm Pharmaceuticals
RYTM
$6.07B
| $273M | 4.99% |
2,546,391
+107,422
|
|
||
4
Ascendis Pharma
ASND
$14.8B
| $231M | 4.22% |
1,081,421
-7,080
|
|
||
5
Apogee Therapeutics
APGE
$4.94B
| $176M | 3.22% |
2,330,651
+978,662
|
|
||
6
Roivant Sciences
ROIV
$21.1B
| $173M | 3.17% |
7,985,461
+617,000
|
|
||
7
Nuvalent
NUVL
$7.97B
| $167M | 3.07% |
1,665,105
+102,769
|
|
||
8
Travere Therapeutics
TVTX
$2.6B
| $163M | 2.99% |
4,278,180
+483,565
|
|
||
|
9
Exact Sciences
EXAS
$19.8B
| $122M | 2.23% |
1,200,487
+735,000
|
|
||
10
Protagonist Therapeutics
PTGX
$6.05B
| $118M | 2.16% |
1,350,425
+320,291
|
|
||
11
Inhibrx
INBX
$1.09B
| $115M | 2.1% |
1,452,707
+125,000
|
|
||
12
Edgewise Therapeutics
EWTX
$3.06B
| $111M | 2.03% |
4,457,974
+662,080
|
|
||
13
Immatics
IMTX
$1.36B
| $109M | 2% |
10,383,456
+1,000,000
|
|
||
14
Spyre Therapeutics
SYRE
$3.22B
| $101M | 1.84% |
3,069,225
+1,839,780
|
|
||
15
Amylyx Pharmaceuticals
AMLX
$1.65B
| $100M | 1.83% |
8,284,882
-667,483
|
|
||
16
Arcellx
ACLX
$6.61B
| $95.6M | 1.75% |
1,466,071
-1,002,282
|
|
||
17
Viridian Therapeutics
VRDN
$2.9B
| $94.7M | 1.73% |
3,042,703
+1,580,303
|
|
||
18
Boston Scientific
BSX
$107B
| $93.3M | 1.71% |
979,000
+669,000
|
|
||
19
Amicus Therapeutics
FOLD
$4.5B
| $90.7M | 1.66% |
6,370,851
|
|
||
20
Zymeworks
ZYME
$1.9B
| $85.9M | 1.57% |
3,261,850
+1,171,187
|
|
||
|
ATXS
21
DELISTED
Astria Therapeutics
ATXS
| $84.9M | 1.56% |
6,485,420
|
|
||
22
MeiraGTx Holdings
MGTX
$596M
| $82.1M | 1.5% |
10,326,103
-2,300,000
|
|
||
23
Artivion
AORT
$1.84B
| $78.6M | 1.44% |
1,722,290
-297,710
|
|
||
|
CNTA
24
Centessa Pharmaceuticals
CNTA
$3.95B
| $73M | 1.34% |
2,917,634
-183,268
|
|
||
|
25
Dyne Therapeutics
DYN
$2.51B
| $68M | 1.25% |
3,478,944
+2,938,500
|
|